title: How companies stall generics and keep themselves healthy.
authors.forename: S G
authors.initials: SG
authors.lastname: Stolberg
authors.forename: J
authors.initials: J
authors.lastname: Gerth
mesh_terms: D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D005252:Fees, Pharmaceutical; D006801:Humans; D010330:Patents as Topic; D004364:Pharmaceutical Preparations; D011224:Prazosin / Q000031:analogs & derivatives*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D004364:Pharmaceutical Preparations; C041226:Terazosin; D011224:Prazosin